Lipid mediators in the nucleus: Their potential contribution to Alzheimer's disease.
暂无分享,去创建一个
[1] N. Zini,et al. Topology of inositol lipid signal transduction in the nucleus , 1999, Journal of cellular physiology.
[2] T. Perlmann,et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. , 2000, Science.
[3] Y. Awasthi,et al. 4-Hydroxynonenal self-limits fas-mediated DISC-independent apoptosis by promoting export of Daxx from the nucleus to the cytosol and its binding to Fas. , 2008, Biochemistry.
[4] S. Monier,et al. Impairment with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occuring during 7-ketocholesterol-induced apoptosis. , 2000, Free radical biology & medicine.
[5] S. Serini,et al. n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. , 2007, Current medicinal chemistry.
[6] D. Adam,et al. Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor , 1998, Journal of leukocyte biology.
[7] A. Howlett,et al. CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells. , 1998, Brain research. Molecular brain research.
[8] A. Martelli,et al. Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? , 2006, Cellular signalling.
[9] G. Barrett. The p75 neurotrophin receptor and neuronal apoptosis , 2000, Progress in Neurobiology.
[10] A. Martelli,et al. Nuclear inositol lipid metabolism: More than just second messenger generation? , 2005, Journal of cellular biochemistry.
[11] D. Russell,et al. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. , 2009, Annual review of biochemistry.
[12] T. Montine,et al. 4‐Hydroxy‐2(E)‐Nonenal Inhibits CNS Mitochondrial Respiration at Multiple Sites , 1999, Journal of neurochemistry.
[13] E. Berdyshev,et al. Cannabinoid receptors and the regulation of immune response. , 2000, Chemistry and physics of lipids.
[14] M. Czubryt,et al. RanGAP-Mediated Nuclear Protein Import in Vascular Smooth Muscle Cells Is Augmented by Lysophosphatidylcholine , 2007, Molecular Pharmacology.
[15] B. Halliwell,et al. Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A2 inhibitors , 2001, Brain Research Reviews.
[16] E. Albi,et al. Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus. , 2008, The Biochemical journal.
[17] L. Horrocks,et al. Phospholipids in the nervous system , 1982 .
[18] M. Schumacher,et al. 25‐hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR , 2009, Journal of neurochemistry.
[19] L. Horrocks,et al. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide , 2007, Journal of neuroscience research.
[20] A. A. Farooqui. Excitotoxicity-Mediated Neurochemical Changes in Neurological Disorders , 2009 .
[21] H. Kölsch,et al. Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17β , 2001, Journal of Neural Transmission.
[22] Cheng Luo,et al. Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.
[23] N. Bazan. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.
[24] J. Wahren,et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. , 1998, Journal of lipid research.
[25] P. Codogno,et al. Increase in Ceramide Level Alters the Lysosomal Targeting of Cathepsin D prior to Onset of Apoptosis in HT-29 Colon Cancer Cells , 2002, Biological chemistry.
[26] O. Gerasimenko,et al. New aspects of nuclear calcium signalling , 2004, Journal of Cell Science.
[27] B. Fahrenkrog. The nuclear pore complex, nuclear transport, and apoptosis. , 2006, Canadian journal of physiology and pharmacology.
[28] E. Albi,et al. The role of intranuclear lipids , 2004, Biology of the cell.
[29] R. Ledeen,et al. Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling** This study was supported by National Institutes of Health grant 2RO1 NS033912. Published, JLR Papers in Press, March 9, 2008. , 2008, Journal of Lipid Research.
[30] T. Willson,et al. Polyunsaturated Fatty Acids Including Docosahexaenoic and Arachidonic Acid Bind to the Retinoid X Receptor α Ligand-binding Domain* , 2004, Molecular & Cellular Proteomics.
[31] A. Gomez-Muñoz. Ceramide 1-phosphate/ceramide, a switch between life and death. , 2006, Biochimica et biophysica acta.
[32] M. V. Magni,et al. Plasmalogens in rat liver chromatin: New molecules involved in cell proliferation , 2004, Journal of cellular physiology.
[33] L. Horrocks,et al. Excitatory Amino Acid Receptors in Brain , 2008 .
[34] M. V. Magni,et al. Nuclear sphingomyelin pathway in serum deprivation‐induced apoptosis of embryonic hippocampal cells , 2006, Journal of cellular physiology.
[35] J. M. Ruiz-Albusac,et al. 25-Hydroxycholesterol has a dual effect on the proliferation of cultured rat astrocytes , 2006, Neuropharmacology.
[36] L. Horrocks,et al. Effect of Retinoic Acid on the Ca2+-Independent Phospholipase A2 in Nuclei of LA-N-1 Neuroblastoma Cells , 2004, Neurochemical Research.
[37] A. Hunt,et al. Dynamic lipidomics of the nucleus , 2006, Journal of cellular biochemistry.
[38] A. Martelli,et al. Nuclear phospholipase C: involvement in signal transduction. , 2005, Progress in lipid research.
[39] A. A. Farooqui. Neural Membranes: A Pandora’s Box of Lipid Mediators , 2009 .
[40] I. Björkhem,et al. Oxysterols and Alzheimer's disease , 2006, Acta neurologica Scandinavica. Supplementum.
[41] M. V. Magni,et al. Sphingomyelin-cholesterol and double stranded RNA relationship in the intranuclear complex. , 2007, Archives of biochemistry and biophysics.
[42] A. A. Farooqui,et al. Changes in Brain Cholesterol Metabolome After Excitotoxicity , 2010, Molecular Neurobiology.
[43] M. Wenk,et al. Non‐targeted profiling of lipids during kainate‐induced neuronal injury , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] I. Emerit,et al. Hydroxynonenal, a component of clastogenic factors? , 1991, Free radical biology & medicine.
[45] L. Horrocks,et al. Retinoic acid-mediated phospholipase A2 signaling in the nucleus , 2004, Brain Research Reviews.
[46] J. Han,et al. 7-Ketocholesterol enhances 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells , 2006, Journal of Neural Transmission.
[47] B. Halliwell,et al. Increase in Cholesterol and Cholesterol Oxidation Products, and Role of Cholesterol Oxidation Products in Kainate‐induced Neuronal Injury , 2003, Brain pathology.
[48] N. Heveker,et al. G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. , 2006, Canadian journal of physiology and pharmacology.
[49] D. Friend,et al. Purification of human lung leukotriene C4 synthase and preparation of a polyclonal antibody. , 1995, American journal of respiratory and critical care medicine.
[50] R. Ledeen,et al. Sphingolipids of the nucleus and their role in nuclear signaling. , 2006, Biochimica et biophysica acta.
[51] A. Martelli,et al. Nuclear inositides: facts and perspectives. , 2004, Pharmacology & therapeutics.
[52] Andrew J. Brown,et al. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. , 2006, The Biochemical journal.
[53] A. A. Spector,et al. Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. , 2005, Microvascular research.
[54] E. Albi,et al. Nuclear membrane sphingomyelin-cholesterol changes in rat liver after hepatectomy. , 1999, Biochemical and biophysical research communications.
[55] B. Halliwell,et al. Distribution of hydroxynonenal-modified proteins in the kainate-lesioned rat hippocampus: evidence that hydroxynonenal formation precedes neuronal cell death. , 2000, Free radical biology & medicine.
[56] E. Millanvoye-Van Brussel,et al. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2. , 2004, The Biochemical journal.
[57] P. D. Drew,et al. Cholesterol oxides induce programmed cell death in microglial cells. , 1998, Biochemical and biophysical research communications.
[58] R. Irvine. Nuclear inositide signalling -- expansion, structures and clarification. , 2006, Biochimica et biophysica acta.
[59] A. Martelli,et al. Nuclear diacylglycerol kinase‐ζ is a negative regulator of cell cycle progression in C2C12 mouse myoblasts , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] L. Horrocks,et al. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. , 2000, Chemistry and physics of lipids.
[61] David S. Park,et al. Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment , 2000, Neurobiology of Aging.
[62] Y. Kim,et al. Prevention of 7-ketocholesterol-induced mitochondrial damage and cell death by calmodulin inhibition , 2007, Brain Research.
[63] P. Bruni,et al. Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response. , 2006, Biochimica et biophysica acta.
[64] A. A. Farooqui. Hot Topics in Neural Membrane Lipidology , 2010 .
[65] T. Okada,et al. Sphingosine Kinase 2 Is a Nuclear Protein and Inhibits DNA Synthesis* , 2003, Journal of Biological Chemistry.
[66] J. Gustafsson,et al. Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. , 2009, Cell stem cell.
[67] J. York,et al. A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. , 2000, Science.
[68] Xianlin Han. Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease. , 2005, Current Alzheimer research.
[69] Andrew J. Brown,et al. Statins Inhibit Synthesis of an Oxysterol Ligand for the Liver X Receptor in Human Macrophages With Consequences for Cholesterol Flux , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[70] G. Baldini,et al. Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. , 2000, Cancer research.
[71] S. Choufani,et al. Proinflammatory Gene Induction by Platelet-Activating Factor Mediated Via Its Cognate Nuclear Receptor1 , 2002, The Journal of Immunology.
[72] I. Pikuleva,et al. Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. , 2003, Biochemistry.
[73] R. Faustino,et al. Ceramide regulation of nuclear protein imports⃞ Published, JLR Papers in Press, December 14, 2007. , 2008, Journal of Lipid Research.
[74] J. Phillis,et al. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders , 2006, Brain Research Reviews.